Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 1/2 1

Status

Completed 9Unknown 3Terminated 3Withdrawn 1Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 24Neoplasm Metastasis 3Ovarian Neoplasms 2Prostatic Neoplasms 1Premenopausal Breast Cancer 1Pancreatic Neoplasms 1Invasive Early Breast Cancer 1First Line Metastatic Breast Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Breast Neoplasms, Male 1Breast Cancer Metastatic 1

Interventions

pembrolizumab 29Capecitabine 24Bevacizumab 23Cyclophosphamide 22Gemcitabine 21Paclitaxel 20Nivolumab 19Fluorouracil 19Docetaxel 18aldesleukin 17Leucovorin 17Irinotecan 17Oxaliplatin 15Interleukin-2 14Radiosurgery 13Cisplatin 13Cetuximab 13fludarabine 12Carboplatin 12Albumin-Bound Paclitaxel 11fludarabine phosphate 10Ipilimumab 10Drug Therapy 10Doxorubicin 10Sunitinib 9Radiotherapy 9Everolimus 9130-nm albumin-bound paclitaxel 9Trastuzumab 8Temozolomide 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Neoplasm Metastasis × exemestane × Clear all
NCT03220178 2022-01-06

PRECYCLE

Palleos Healthcare GmbH

Phase 4 Terminated
532 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00905021 2020-07-24

EXTENT

Baylor Breast Care Center

Phase 1/2 Terminated
4 enrolled 6 charts
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

The Netherlands Cancer Institute

Phase 2/3 Terminated
10 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡